Currently out of the existing stock ratings of Mark Massaro, 272 are a BUY (85.27%), 38 are a HOLD (11.91%), 9 are a SELL (2.82%).

Mark Massaro

Work Performance Price Targets & Ratings Chart

Analyst Mark Massaro, currently employed at BTIG, carries an average stock price target met ratio of 53.35% that have a potential upside of 33.39% achieved within 197 days.

Mark Massaro’s has documented 621 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MDXH, MDxHealth SA ADR at 13-Nov-2025.

Wall Street Analyst Mark Massaro

Analyst best performing recommendations are on TKNO (ALPHA TEKNOVA).
The best stock recommendation documented was for GHDX (GENOMIC HEALTH) at 11/7/2018. The price target of $82 was fulfilled within 2 days with a profit of $8.18 (9.07%) receiving and performance score of 45.35.

Average potential price target upside

of $5583.33 (57.92%) on TTOO (T2 BIOSYSTMS).
of $39.07 (15.45%) on ILMN (ILLUMINA).
of $36.81 (14.04%) on IDXX (IDEXX LABORATORIES).

ADPT Adaptive Biotechnologies Corp BLI Berkeley Lights DGX Quest Diagnostics EXAS EXACT Sciences GH Guardant Health GHDX Genomic Health HOLX Hologic HSKA Heska HTGM HTG Molecular Diagnostics IDXX IDEXX Laboratories LH Laboratory of America Holdings NTRA Natera OCX OncoCyte Corp OSUR OraSure Technologies QDEL Quidel QTNT Quotient Ltd RNLX Renalytix AI TTOO T2 Biosystms DNA Ginkgo Bioworks Holdings ILMN Illumina LUCD Lucid Diagnostics NEO NeoGenomics PSNL Personalis TLIS Talis Biomedical Corp VIVO Meridian Bioscience DMTK DermTech HLTH Cue Health LMDX LumiraDx Ltd MXCT MaxCyte SMFR Sema4 Holdings Corp XGN Exagen CDNA Caredx GNMK GenMark Diagnostics AKYA Akoya Biosciences CEMI Chembio Diagnostics CSTL Castle Biosciences MDXH MDxHealth SA ADR BNGO Bionano Genomics CERS Cerus TKNO Alpha Teknova ZTS Zoetis QTRX Quanterix Corp SOPH Sophia Genetics SA

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Tejas Savant (MORGAN STANLEY)